Delayed clinical improvement after deep brain stimulation–related subdural hematoma

Report of 4 cases

Genko Oyama Departments of Neurology and

Search for other papers by Genko Oyama in
Current site
Google Scholar
PubMed
Close
 M.D., Ph.D.
,
Michael S. Okun Departments of Neurology and
Neurosurgery, University of Florida Movement Disorders Center, Gainesville; and

Search for other papers by Michael S. Okun in
Current site
Google Scholar
PubMed
Close
 M.D.
,
Theresa A. Zesiewicz Department of Neurology, College of Medicine, University of South Florida Health, Tampa, Florida

Search for other papers by Theresa A. Zesiewicz in
Current site
Google Scholar
PubMed
Close
 M.D.
,
Tiffany Tamse Departments of Neurology and

Search for other papers by Tiffany Tamse in
Current site
Google Scholar
PubMed
Close
 B.S.
,
Janet Romrell Departments of Neurology and

Search for other papers by Janet Romrell in
Current site
Google Scholar
PubMed
Close
 P.A.
,
Pamela Zeilman Departments of Neurology and

Search for other papers by Pamela Zeilman in
Current site
Google Scholar
PubMed
Close
 A.R.N.P.
, and
Kelly D. Foote Neurosurgery, University of Florida Movement Disorders Center, Gainesville; and

Search for other papers by Kelly D. Foote in
Current site
Google Scholar
PubMed
Close
 M.D.
Restricted access

Purchase Now

USD  $45.00

JNS + Pediatrics - 1 year subscription bundle (Individuals Only)

USD  $525.00

JNS + Pediatrics + Spine - 1 year subscription bundle (Individuals Only)

USD  $624.00
USD  $45.00
USD  $525.00
USD  $624.00
Print or Print + Online Sign in

Object

The purpose of this paper is to present 4 cases that illustrate the management and outcome of subdural hematoma (SDH) following deep brain stimulation (DBS) lead implantation.

Methods

The authors identified 4 cases of SDH following DBS lead implantation from a pool of 500 consecutive lead implantations (incidence 0.08%) performed at the University of Florida. Cases were characterized by chart review, serial Unified Parkinson's Disease Rating Scale evaluations, and changes on serial postoperative imaging studies.

Results

Two of the 4 patients with DBS-related SDH were clinically symptomatic. In the other 2 cases the SDH was incidentally discovered on routine postoperative lead localization imaging studies. None of the patients required craniotomy for evacuation of the SDH in the acute phase. Three of the 4 cases were managed with bur hole drainage in the chronic phase, and one was successfully managed nonoperatively. In all 4 cases, thresholds for stimulationinduced side effects were lower during initial postoperative programming than during intraoperative macrostimulation. Expected clinical improvement from DBS was achieved without lead revision in all 4 cases, but only after a significant delay.

Conclusions

Subdural hematoma is a rare and potentially avoidable complication of DBS that does not typically mandate acute hematoma evacuation or hardware revision and does not preclude an excellent outcome from DBS therapy. The clinical picture and apparent lead position tend to improve with time, and it may be wise to delay repositioning of an ineffective DBS lead following a hemorrhage until the DBS lead and surrounding brain tissue have settled into their final position and the insulted brain has had sufficient time to recover.

Abbreviations used in this paper:

DBS = deep brain stimulation; PD = Parkinson disease; SDH = subdural hematoma; STN = subthalamic nucleus; UPDRS = United Parkinson's Disease Rating Scale.
  • Collapse
  • Expand
  • 1

    Beric A, , Kelly PJ, , Rezai A, , Sterio D, , Mogilner A, & Zonenshayn M, et al.: Complications of deep brain stimulation surgery. Stereotact Funct Neurosurg 77:7378, 2001

  • 2

    Binder DK, , Rau GM, & Starr PA: Risk factors for hemorrhage during microelectrode-guided deep brain stimulator implantation for movement disorders. Neurosurgery 56:722732, 2005

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 3

    Goodman RR, , Kim B, , McClelland S III, , Senatus PB, , Winfield LM, & Pullman SL, et al.: Operative techniques and morbidity with subthalamic nucleus deep brain stimulation in 100 consecutive patients with advanced Parkinson's disease. J Neurol Neurosurg Psychiatry 77:1217, 2006

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 4

    Harding AE: Subdural haematoma in two patients with chronic neurological disorders. Br Med J (Clin Res Ed) 288:19861987, 1984

  • 5

    Herzog J, , Volkmann J, , Krack P, , Kopper F, , Pötter M, & Lorenz D, et al.: Two-year follow-up of subthalamic deep brain stimulation in Parkinson's disease. Mov Disord 18:13321337, 2003

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 6

    Isaka Y, , Imaizumi M, , Itoi Y, , Ashida K, & Horibe K: Cerebral blood flow imaging with technetium-99m-HMPAO SPECT in a patient with chronic subdural hematoma: relationship with neuropsychological test. J Nucl Med 33:246248, 1992

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 7

    Ishikawa T, , Kawamura S, , Hadeishi H, , Suzuki A, , Yasui N, & Shishido F, et al.: Uncoupling between CBF and oxygen metabolism in a patient with chronic subdural haematoma: case report. J Neurol Neurosurg Psychiatry 55:401403, 1992

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 8

    Kenney C, , Simpson R, , Hunter C, , Ondo W, , Almaguer M, & Davidson A, et al.: Short-term and long-term safety of deep brain stimulation in the treatment of movement disorders. J Neurosurg 106:621625, 2007

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 9

    Koller W, , Pahwa R, , Busenbark K, , Hubble J, , Wilkinson S, & Lang A, et al.: High-frequency unilateral thalamic stimulation in the treatment of essential and parkinsonian tremor. Ann Neurol 42:292299, 1997

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 10

    Markwalder TM: Chronic subdural hematomas: a review. J Neurosurg 54:637645, 1981

  • 11

    Pollak P, , Fraix V, , Krack P, , Moro E, , Mendes A, & Chabardes S, et al.: Treatment results: Parkinson's disease. Mov Disord 17:Suppl 3 S75S83, 2002

  • 12

    Salvant JB Jr, & Muizelaar JP: Changes in cerebral blood flow and metabolism related to the presence of subdural hematoma. Neurosurgery 33:387393, 1993

  • 13

    Servello D, , Sassi M, , Bastianello S, , Poloni GU, , Mancini F, & Pacchetti C: Electrode displacement after intracerebral hematoma as a complication of a deep brain stimulation procedure. Neuropsychiatr Dis Treat 5:183187, 2009

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 14

    Simuni T, , Jaggi JL, , Mulholland H, , Hurtig HI, , Colcher A, & Siderowf AD, et al.: Bilateral stimulation of the subthalamic nucleus in patients with Parkinson disease: a study of efficacy and safety. J Neurosurg 96:666672, 2002

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 15

    Suman S, , Meenakshisundaram S, & Woodhouse P: Bilateral chronic subdural haematoma: a reversible cause of parkinsonism. J R Soc Med 99:9192, 2006

  • 16

    Umemura A, , Jaggi JL, , Hurtig HI, , Siderowf AD, , Colcher A, & Stern MB, et al.: Deep brain stimulation for movement disorders: morbidity and mortality in 109 patients. J Neurosurg 98:779784, 2003

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 17

    Wiest RG, , Burgunder JM, & Krauss JK: Chronic subdural haematomas and Parkinsonian syndromes. Acta Neurochir (Wien) 141:753758, 1999

Metrics

All Time Past Year Past 30 Days
Abstract Views 969 265 26
Full Text Views 180 22 7
PDF Downloads 209 15 0
EPUB Downloads 0 0 0